Table 5.
Multivariate analysis of overall survival
| Variables | HR (95%CI) | P value |
|---|---|---|
| Analysis with CD8 expression | ||
| CD8 change | 0.73(0.55-0.97) | 0.028 |
| Gender | ||
| Male | 1 | |
| Female | 2.51(1.06-5.92) | 0.036 |
| Tumor differentiation | ||
| Poorly differentiated | 1 | |
| Well or moderately differentiated | 0.59(0.26-1.33) | 0.203 |
| Downstaging | ||
| Yes | 1 | |
| No | 1.18(0.49-2.87) | 0.709 |
| Tumor regression grading (Mandard system) | ||
| Grade 2 or 3 | 1 | |
| Grade 4 | 2.46(0.93-6.49) | 0.070 |
| Analysis with PD-1 expression | ||
| PD-1 change | 0.76(0.60-0.97) | 0.027 |
| Gender | ||
| Male | 1 | |
| Female | 1.72(0.72-4.13) | 0.224 |
| Tumor differentiation | ||
| Poorly differentiated | 1 | |
| Well or moderately differentiated | 0.47(0.20-1.08) | 0.075 |
| Downstaging | ||
| Yes | 1 | |
| No | 1.14(0.47-2.74) | 0.772 |
| Tumor regression grading (Mandard system) | ||
| Grade 2 or 3 | 1 | |
| Grade 4 | 2.63(0.98-7.06) | 0.054 |
| Analysis with PD-L1 expression | ||
| PD-L1 | 0.67(0.45-0.98) | 0.038 |
| Gender | ||
| Male | 1 | |
| Female | 1.47(0.57-3.79) | 0.429 |
| Tumor differentiation | ||
| Poorly differentiated | 1 | |
| Well or moderately differentiated | 0.50(0.22-1.17) | 0.109 |
| Downstaging | ||
| Yes | 1 | |
| No | 1.30(0.56-3.01) | 0.537 |
| Tumor regression grading (Mandard system) | ||
| Grade 2 or 3 | 1 | |
| Grade 4 | 2.69(1.01-7.17) | 0.048 |